Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect

References

• Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 2005; 19: 373–87
   PubMed Web of Science ®Google Scholar
• Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992; 35: 188–92
   PubMed Web of Science ®Google Scholar
• Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989; 169: 345–50
   PubMed Web of Science ®Google Scholar
• Vader LW, De Ru A, van der WY, Kooy YM, Benckhuijsen W, Mearin ML, et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002; 195: 643–9
   PubMed Web of Science ®Google Scholar
• Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002; 97: 695–9
   PubMed Web of Science ®Google Scholar
• Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, et al. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 2003; 61: 308–16
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, Wijmenga C. Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann Med 2006; 38: 578–91
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341–4
   PubMed Web of Science ®Google Scholar
• van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007; 39: 827–9
   PubMed Web of Science ®Google Scholar
• Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383–91
   PubMed Web of Science ®Google Scholar
• George EK, Mearin ML, Franken HC, Houwen RH, Hirasing RA, Vandenbroucke JP. Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence?. Gut 1997; 40: 61–6
   PubMed Web of Science ®Google Scholar
• Steens RF, Csizmadia CG, George EK, Ninaber MK, Hira Sing RA, Mearin ML. A national prospective study on childhood celiac disease in the Netherlands 1993–2000: an increasing recognition and a changing clinical picture. J Pediatr 2005; 147: 239–43
   PubMed Web of Science ®Google Scholar
• Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999; 353: 813–4
   PubMed Web of Science ®Google Scholar
• Mearin ML. Celiac disease among children and adolescents. Curr Probl Pediatr Adolesc Health Care 2007; 37: 86–105
   PubMedGoogle Scholar
• Mearin ML, Koninckx CR, Biemond I, Polanco I, Pena AS. Influence of genetic factors on the serum levels of antigliadin antibodies in celiac disease. J Pediatr Gastroenterol Nutr 1984; 3: 373–7
   PubMed Web of Science ®Google Scholar
• Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993; 41: 173–7
   PubMed Web of Science ®Google Scholar
• Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 1994; 40: 138–42
   PubMed Web of Science ®Google Scholar
• Zubillaga P, Vidales MC, Zubillaga I, Ormaechea V, Garcia-Urkia N, Vitoria JC. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr 2002; 34: 548–54
   PubMed Web of Science ®Google Scholar
• Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R, et al. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol 2006; 41: 191–9
   PubMed Web of Science ®Google Scholar
• Mustalahti K, Holopainen P, Karell K, Maki M, Partanen J. Genetic dissection between silent and clinically diagnosed symptomatic forms of coeliac disease in multiplex families. Dig Liver Dis 2002; 34: 842–5
   PubMedGoogle Scholar
• Mearin ML, Biemond I, Pena AS, Polanco I, Vazquez C, Schreuder GT, et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983; 24: 532–7
   PubMed Web of Science ®Google Scholar
• Mearin ML, Bouquet J, Mourad N, Schoorel E, Sinaasappel M, Biemond I, et al. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet 1985; 27: 45–50
   PubMed Web of Science ®Google Scholar
• Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003; 100: 12390–5
   PubMed Web of Science ®Google Scholar
• Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK, et al. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909–11
   PubMed Web of Science ®Google Scholar
• Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology 1992; 102: 330–54
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185–94
   PubMed Web of Science ®Google Scholar
• Verduyn W, Doxiadis II, Anholts J, Drabbels JJ, Naipal A, D'Amaro J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993; 37: 59–67
   PubMed Web of Science ®Google Scholar
• Schouten HJA. Klinische statistiek, een praktische inleiding in methodologie en analyse. Bohn Satfleu Van loghum Houten/Diegem. 1999
   Google Scholar
• Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, et al. The HLA dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Int J Immunogenet 2005; 32: 19–69
   PubMed Web of Science ®Google Scholar
• Jores RD, Frau F, Cucca F, Grazia CM, Orru S, Rais M, et al. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand J Gastroenterol 2007; 42: 48–53
   PubMed Web of Science ®Google Scholar
• Al Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006; 4: 315–9
   PubMed Web of Science ®Google Scholar
• Greco L, Percopo S, Clot F, Bouguerra F, Babron MC, Eliaou JF, et al. Lack of correlation between genotype and phenotype in celiac disease. J Pediatr Gastroenterol Nutr 1998; 26: 286–90
   PubMed Web of Science ®Google Scholar
• Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, , et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol 2007;5:1399–405.
   PubMed Web of Science ®Google Scholar